20
Apotex Pharmachem Inc, based in Canada, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE USP, with a corresponding US DMF Number 33173.
Remarkably, this DMF maintains an Active status since its submission on November 02, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 12, 2019, and payment made on November 06, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II